Ungar, B., Ben-Shatach, Z., Selinger, L., Malik, A., Albshesh, A., Ben-Horin, S., . . . Carter, D. (2019). Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease. United European Gastroenterol J.

Ungar, Bella, Zohar Ben-Shatach, Limor Selinger, Alona Malik, Ahmad Albshesh, Shomron Ben-Horin, Rami Eliakim, Uri Kopylov, and Dan Carter. "Lower Adalimumab Trough Levels Are Associated With Higher Bowel Wall Thickness in Crohn's Disease." United European Gastroenterol J 2019.

Ungar, Bella, et al. "Lower Adalimumab Trough Levels Are Associated With Higher Bowel Wall Thickness in Crohn's Disease." United European Gastroenterol J 2019.